[2P-0080] Combination of paclitaxel and sorafenib suppresses the self-renewal of cancer stem cells

〇Hend M Nawara¹、Said M Afify^1,2、Du Juan¹、Hassan Ghmkin¹、Hager M Mansour¹、Amira Osman¹、Hagar A Abu Quora¹、Maram H Zahra¹、Akimasa Seno⁴、Nobuhiro Okada¹、Masaharu Seno ^1,3 (1.Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University、2.Division of Biochemistry, Faculty of Science, Menoufia University、3.Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University、4.Okayama University Research Laboratory of Stem Cell Engineering in Detroit, IBio, Wayne State University)

combination therapy 、paclitaxel 、 sorafenib 、cancer stem cells